Sensorion Seeks Partner For Inner Ear Disorder Drug
Executive Summary
Sensorion CEO Nawal Ouzren speaks to Scrip's Lucie Ellis on the sidelines of the recent BIO-Europe partnering meeting about the company's two clinical-stage programs that are targeting inner ear conditions.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.